Inovio Pharma (INO) Misses Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.21 --0%
EPS Growth %: +75.9%
Financial Fact:
Net loss attributable to Inovio Pharmaceuticals, Inc.: -20.76M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +75.9%
Financial Fact:
Net loss attributable to Inovio Pharmaceuticals, Inc.: -20.76M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.39), $0.14 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $273 thousand versus the consensus estimate of $1.21 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Is the S&P 500 in an “earnings bubble”? Goldman weighs in
- Moncler SpA (MONC:IM) (MONRY) PT Lowered to EUR50 at Morgan Stanley
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
